Synthesis of a novel series of 3-oxo-2,4-dioxobicyclo[3.2.1]octanes: additional evidence for two thromboxane receptor subtypes.
- 1 September 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (17) , 2103-2106
- https://doi.org/10.1016/s0960-894x(01)80110-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A safe and efficient method for conversion of 1,2- and 1,3-diols to cyclic carbonates utilizing triphosgeneTetrahedron Letters, 1993
- The F2-isoprostane, 8-epi-prostaglandin F2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonistProstaglandins, 1992
- Platelet and vascular thromboxane A2/prostaglandin H2 receptors: Evidence for different subclasses in the ratBiochemical Pharmacology, 1991
- Heterogeneity of thromboxane A2 (TP-) receptors: evidence from antagonist but not agonist potency measurementsBritish Journal of Pharmacology, 1991
- Cloning and expression of cDNA for a human thromboxane A2 receptorNature, 1991
- Biochemical characterization and comparison of rat thromboxane A2/prostaglandin H2 receptors in platelets and cultured aortic smooth muscle cellsBiochemical Pharmacology, 1989
- Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonistsEuropean Journal of Pharmacology, 1988
- Synthesis and platelet aggregation inhibiting activity of prostaglandin D analogsJournal of Medicinal Chemistry, 1983
- Studies with trialkylsilyltriflates: new syntheses and applicationsTetrahedron Letters, 1981
- Esterification and Alkylation Reactions Employing IsoureasSynthesis, 1979